Table 2.

Correlations between the clinicopathological factors and density of the CD23⁺ cells

Characteristics		N	CD23
			High	Low	p-Value
Age	< 70	152	39	113
	≥ 70	84	20	64	0.753
Sex	Male	194	44	150
	Female	42	15	27	0.086
History of other cancer	No	204	51	153
	Yes	32	8	24	1.000
Location	Ce / Ut	21	5	16
	Mt	142	34	108
	Lt / Ae	73	20	53	0.852
cT category	T 1 / 2	111	28	83
	T 3 / 4	125	31	94	0.940
cN category	N -	88	22	66
	N +	148	37	111	1.000
cStage category	0 - II	119	31	88
	III / IVa	117	28	89	0.707
Neoadjuvant Chemotherapy	No	84	15	69
	Yes	152	44	108	0.055
Myelosuppression grade	≤ 2	131	35	96
	3	14	4	11
	4	7	5	1	0.058
pT category	T 1a / 1b / 2	137	36	101
	T 3 / 4a	99	23	76	0.593
pN category	N 0	103	27	76
	N 1 - 4	133	32	101	0.705
pStage category	0 - II	143	39	104
	III / IVa	93	20	73	0.314
Histological therapeutic effect	0 / 1a	114	32	82
	1b / 2	38	12	28	0.681
Adjuvant chemotherapy	No	135	38	97
	Yes	101	21	80	0.194

Ce Cervical esophagus, Ut Upper thoracic esophagus, Mt Middle thoracic esophagus, Lt lower thoracic esophagus, Ae Abdominal eso-phagus, T Depth of invasion, N Nodal status